Denosumab biosimilar

denosumab · Enzene Biosciences Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Denosumab biosimilar, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers [Phase 1]

See pricing